Ironwood Pharmaceuticals
IRWD
129 hedge funds and large institutions have $1.02B invested in Ironwood Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
348% more call options, than puts
Call options by funds: $11.9M | Put options by funds: $2.66M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Group One Trading
Chicago,
Illinois
| $22K | +$32.1K | +2,647 | New |
|
|
GT
127
Glenmede Trust
Philadelphia,
Pennsylvania
| $19K | +$28.9K | +2,388 | New |
|
128
US Bancorp
Minneapolis,
Minnesota
| $6K | +$8.68K | +716 | New |
|
|
ST
129
SpiderRock Trading
Chicago,
Illinois
| $2K | – | – | – |
|
|
RFS
130
Rockefeller Financial Services
New York
| – | +$24 | +2 | New |
|
IRWD Hedge Fund Activity: Q2 2013 in Review
129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q2 2013, worth a combined $1.02B.
Buyers outnumbered sellers: 129 funds opened new IRWD positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.
- 129 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.02B of Ironwood Pharmaceuticals stock for Q2 2013.
- 129 funds opened new Ironwood Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +129 holders.
Based on aggregated 13F filings for Q2 2013.